Condition
Nonspecific Interstitial Pneumonia
Total Trials
6
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown2
Recruiting2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT03836417Completed
Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
NCT03800017Not ApplicableRecruiting
Skeletal Muscle Function in Interstitial Lung Disease
NCT05007340Recruiting
ILD-SARDs Registry and Biorepository
NCT02827734Unknown
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
NCT02596841Completed
Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias
NCT00637065Phase 4Unknown
Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
Showing all 6 trials